BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//http://www.ucmr.umu.se//NONSGML kigkonsult.se iCalcreator 2.29.29
 //
CALSCALE:GREGORIAN
METHOD:PUBLISH
UID:9ba1a370-3482-4594-8eb8-f43ad7b695a1
X-WR-CALNAME:JCal Pro Calendar
X-WR-CALDESC:Your online events calendar
X-WR-TIMEZONE:Europe/Stockholm
BEGIN:VTIMEZONE
TZID:Europe/Stockholm
BEGIN:STANDARD
TZNAME:CET
DTSTART:20251026T030000
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
RDATE:20261025T030000
END:STANDARD
BEGIN:DAYLIGHT
TZNAME:CEST
DTSTART:20260329T020000
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
RDATE:20270328T020000
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VEVENT
UID:b19863b60a719aad7fe0a497d688b4f9http://www.ucmr.umu.se
DTSTAMP:20260429T225921Z
CATEGORIES:Seminar
DESCRIPTION:<br /><strong>EMBL Partnership for Molecular Medicine (FIMM - M
 IMS - NCMM) joint Special Seminar at the Biomedicum in Helsinki.</strong><
 br />Video transfer of the talk to Umeå and Oslo simultanously.<br /><br /
 ><strong>John Overington</strong>\, EMBL Outstation - Hinxton\, European B
 ioinformatics Institute\, Cambridge\, UK<br /><br /><strong>'A data mining
  synthesis approach to the discovery of impersonalised\, robust and safe t
 herapies'</strong><br /><br /><strong>Abstract:</strong><br /><span style=
 'font-size: x-small\;'>Adverse Drug Reactions\, ADRs\, are a major burden 
 on healthcare systems\, and arguably\, if patients can be stratified\, mor
 e novel therapies\, tolerable in particular genotyped groups could be deve
 loped and launched. We have taken a data synthesis approach to explore ADR
 s and some of the underlying molecular recognition and pharmacokinetic con
 cepts. We then derived a novel drug combination strategy which theoretical
 ly can greatly improve the safety of current therapies and also lead to mo
 re predictable and consistent patient population response.</span><br /><br
  /><a class='jce_file' href='images/stories/documents/John_Overington_FIMM
 _Special_Seminar_talk_ad.pdf' target='_blank'><img class='jce_icon' src='p
 lugins/editors/jce/tiny_mce/plugins/filemanager/img/ext/pdf_small.gif' sty
 le='border: 0px\; vertical-align: middle\;' alt='pdf' /> Summary for downl
 oad</a><br /><br /><strong>Place:</strong> Major Groove\, Department of Mo
 lecular Biology\, bldg 6L\, University Hospital Area<br /><br /><strong>Or
 ganizer in Sweden:</strong> Åke Forsberg<br /><strong>Host at FIMM in Finl
 and:</strong> Heidi Virtanen<br /><strong></strong>
DTSTART;TZID=Europe/Stockholm:20120531T103000
DTEND;TZID=Europe/Stockholm:20120531T113000
SUMMARY:Video-Transfer-Seminar - John Overington: A data mining synthesis a
 pproach to the discovery of impersonalised\, robust and safe therapies
URL:http://www.ucmr.umu.se/about-ucmr/events/162-ucmr-calendar/164-seminar/
 201-video-transfer-seminar-john-overington-a-data-mining-synthesis-approac
 h-to-the-discovery-of-impersonalised-robust-and-safe-therapies.html
X-ALT-DESC;FMTTYPE=TEXT/HTML:<br /><strong>EMBL Partnership for Molecular M
 edicine (FIMM - MIMS - NCMM) joint Special Seminar at the Biomedicum in He
 lsinki.</strong><br />Video transfer of the talk to Umeå and Oslo simultan
 ously.<br /><br /><strong>John Overington</strong>\, EMBL Outstation - Hin
 xton\, European Bioinformatics Institute\, Cambridge\, UK<br /><br /><stro
 ng>'A data mining synthesis approach to the discovery of impersonalised\, 
 robust and safe therapies'</strong><br /><br /><strong>Abstract:</strong><
 br /><span style='font-size: x-small\;'>Adverse Drug Reactions\, ADRs\, ar
 e a major burden on healthcare systems\, and arguably\, if patients can be
  stratified\, more novel therapies\, tolerable in particular genotyped gro
 ups could be developed and launched. We have taken a data synthesis approa
 ch to explore ADRs and some of the underlying molecular recognition and ph
 armacokinetic concepts. We then derived a novel drug combination strategy 
 which theoretically can greatly improve the safety of current therapies an
 d also lead to more predictable and consistent patient population response
 .</span><br /><br /><a class='jce_file' href='images/stories/documents/Joh
 n_Overington_FIMM_Special_Seminar_talk_ad.pdf' target='_blank'><img class=
 'jce_icon' src='plugins/editors/jce/tiny_mce/plugins/filemanager/img/ext/p
 df_small.gif' style='border: 0px\; vertical-align: middle\;' alt='pdf' /> 
 Summary for download</a><br /><br /><strong>Place:</strong> Major Groove\,
  Department of Molecular Biology\, bldg 6L\, University Hospital Area<br /
 ><br /><strong>Organizer in Sweden:</strong> Åke Forsberg<br /><strong>Hos
 t at FIMM in Finland:</strong> Heidi Virtanen<br /><strong></strong>
END:VEVENT
END:VCALENDAR
